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ABSTRACT The stepwise movements generated by myosin, dynein, and kinesin were observed in living cells in an attempt to
understand the molecular mechanisms of movement within cells. First, the sequential process of the transport of vesicles, including
human epidermal factor 2 receptor, after endocytosis was observed for long periods in three dimensions using quantum dots
(QDs) and a three-dimensional confocal microscope. QD vesicles, after being endocytosed into the cells, moved along the mem-
brane by transferring actin ﬁlaments and were then rapidly transported toward the nucleus along microtubules. Second, the
position of vesicles was detected with a precision up to 1.9 nm and 330 ms using a new two-dimensional tracking method. The
movement of the QDs transported by myosin VI lying just beneath the cell membrane consisted of 29- and 15-nm steps with a
transition phase between these two steps. QD vesicles were then transported toward the nucleus or away from the nucleus
toward the cell membrane with successive 8-nm steps. The stepwise movements of these motor proteins in cells were observed
using new imaging methods that allowed the molecular mechanisms underlying trafﬁc to and from the membrane to be
determined.
INTRODUCTION
Motor proteins such as myosin, kinesin, and dynein play roles
in cell motility, such as vesicle transport, mitosis, and muscle
contraction (1,2). To understand the molecular mechanisms
of this motility, an in vitro motility assay employing motor
proteins and methods for detecting single molecules of pu-
riﬁed motor proteins was developed using optical tweezers
and ﬂuorescence molecules (3–8). Single kinesin-1 moves
processively using 8-nm steps at a maximum velocity of;900
nm/s at room temperature and produces forces of ;7 pN
(7). Dynein also proceeds using 8-nm steps and produces
forces of;7 pN (9,10). Myosin V and VI move processively
with step sizes of ;36 and ;30 nm, respectively, at a max-
imum velocity of 300–600 nm/s and produce forces of 2–3
pN (11–14). The movements of kinesin, dynein, and myosin
V and VI have been explained by a ‘‘hand-over-hand’’
model (8,10,15–18).
It is not known if these detailed molecular functions op-
erate in living cells. Physiological conditions in the cell envi-
ronment are very different from those in in vitro assays where
the experiments are performed; for example, the ion com-
position is different in the cells and the assays cells have
adaptor proteins and cytoskeletal networks that are not pres-
ent in the assays. Therefore, it is crucial to measure the mo-
lecular functions of motor proteins in cells to understand the
molecular mechanisms of vesicle transport by motor pro-
teins. The movement of kinesin in cells can be detected with
nanometer accuracy using a cross correlation analysis of the
differential interference contrast of the image (19). Recently,
the transport of peroxisomes in cells has been detected with
nanometer accuracy using GFP-labeled peroxisomes in Dro-
sophila S2 cells (20). The 8-nm steps of presumably dynein
during inward transport have been detected using ‘‘ﬂuores-
cence imaging with one-nanometer accuracy’’ (FIONA) meth-
ods (8,20). Green ﬂuorescent protein (GFP) is a very useful
protein to investigate molecular mechanisms in cells. How-
ever, the bleaching of the ﬂuorescence signal of single GFP
molecules in cells is rapid, making it unsuitable for long-term
observations with FIONA (16,17,21,22). The bright and
stable ﬂuorescence particles, quantum dots (QDs), are useful
for detecting the position of the proteins with a high pre-
cision for long periods of time because QDs take longer to
photobleach than GFP (10,18,23–26).
Vesicle transport is an excellent model for exploring
motor function in cells, because both actin- and microtubule-
based motors are involved in the transport. For example,
endocytosis of a membrane protein, such as human epider-
mal growth factor receptor 1 (HER1), is a multistep process
involving several different motor proteins. The endocytosis
is initiated by the clustering of clathrin, dynamin, and many
other proteins triggered by a ligand binding to HER1 (27).
The vesicle then removes the clathrin coat, and is transported
via an actin-based motor, myosin VI (28,29). The vesicle is
then switched to the microtubule-based motor and trans-
ported toward the nucleus by dynein and away from the
nucleus by kinesin (1,30). Some endocytic vesicles reattach
to the membrane in what is known as the recycling circuit
(31–33). The recycling vesicles could be transported via
myosin V (34,35).
Endocytosis of human epidermal growth factor receptor 2
(HER2), one of the HER family, simpliﬁes the experimental
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setup because HER2 does not have a ligand binding step
(36,37). Therefore, the ﬂuorescence labeled antibody de-
livers the vesicle and/or switching to the motor proteins in a
living cell without using a ligand (24,25). Furthermore, there
is special antibody against HER2 (Trastuzumab), which in-
hibits the recycling circuit (38,39). The signaling pathway
can be greatly simpliﬁed if the recycling of the endosome is
excluded. This allows the actual steps involved in the trans-
port processes to be separated from the ﬁssion process. In
this study, the movements of motor proteins in a cell need to
be visualized for extended periods of time. To achieve this,
stable and intense QDs were bound to anti-HER2 antibody,
which were then endocytosed into breast cancer cells in
which HER2 had been overexpressed on the cell membrane
(31,39,40). The QDs containing vesicle could be detected for
periods of time up to 330 ms and at a spatial precision of;2
nm using a newly developed analytical method with a higher
temporal resolution without a reduction in the observation
area. The stepwise movements and velocities of myosin VI,
dynein, and kinesin reported in puriﬁed proteins were con-
ﬁrmed in this cell line. An unexpected transition between the
small and large step sizes produced by myosin VI in vesicle
transport in a living cell was observed only in these cells.
MATERIALS AND METHODS
Preparation of anti-HER2-QDs
The ﬂuctuation of the ﬂuorescent intensity of a single QD caused by the
blinking was obvious (Supplementary Fig. S1 A, Supplementary Material).
We could not analyze the position of a single QD when the QD was in the
nonﬂuorescent state. The number of nonﬂuorescent single QDs was mini-
mized by condensing multiple QD into a single one similar to the previous
study (10) (Fig. S1, B–D). Multiple QDs were cross-linked by ethylene-
diamine-carbodiimide (EDC) using anti-HER2 antibody. The procedure to
make the condensed QD via anti-HER2 antibody (anti-HER2-QD) is
described as follows: 50 ml of 2 mMQD solution (emission 605 nm, Evitag;
Evidot, Evident Technologies, Troy, NY), 450 ml of 50 mM MES (pH 5.0)
and 500ml of 20 mg/ml EDC (Pierce, Rockwell, IL) in 50 mMMES (pH 5.0)
weremixed and incubated for 5min at 25C. After centrifugation (330,0003
g, 20min, 25C), the pelletwas suspended in 160ml of a 250-mMHEPES (pH
8.0) solution. Then, 40ml of a 1-mg/ml solution of anti-HER2 (Trastuzumab;
Genetics, Chugai Pharmaceuticals, Tokyo, Japan) was added to the solution,
and incubated for 30 min at 25C. After the addition of 200 ml of 50 mg/ml
bovine serum albumin (BSA), the solution was cooled to 4C. To remove the
free anti-HER2, theQDswere rinsed three times in 200ml of 100mMHEPES
and 5mg/ml BSA using centrifugation (330,0003 g, 20 min, 4C). The anti-
HER2 coated QDs were resuspended in 100 mM HEPES (pH 8.0). The
supernatant was used after centrifuging at 40,0003 g for 3 min at 4C.
Culturing of KPL4 cells and drug treatment
Human breast cancer cells, KPL-4, in which HER2 was overexpressed on
the cell membrane, were cultured in Dulbecco’s modiﬁed eagle’s medium
(DMEM) (GIBCO, Carlsbad, CA) medium with 5% fetal bovine serum
(FBS) (GIBCO) at 37C in 5% CO2. One hour before the QD experiment,
the culture medium was exchanged for DMEM without FBS. Cells were
then incubated for 2 h in DMEM medium containing 0.2 nM anti-HER2-
QD. After washing the free anti-HER2-QDs from the medium, the cell was
incubated for 2–12 h in DMEM medium containing 10% FBS. The QD
experiments were performed at 30C or 20C on the microscope. To de-
polymerize the microtubules, the cells were incubated in a medium containing
40 mM nocodazole for 10 min just before the experiment. To depolymerize
the actin ﬁlaments, the cells were incubated in a medium containing 10 mM
cytochalasin D for 10 min before the experiments. Nocodazole or cytocha-
lasin D was present in the medium throughout the experiments.
Immunoﬂuorescence microscopy
KPL-4 cells were stained and ﬁxed using a previously described method
(41). Cells that had been ﬁxed were treated with phalloidine-rhodamine
(Molecular Probe, Eugene, OR), anti-tubulin (Molecular Probe A11126), and
anti-rabbit immunoglobulin G-ﬂuorescein isothiocyanate (IgG-FITC) (Sigma
F7512, St. Louis, MO). Immunoﬂuorescence images were taken under a con-
focal microscope (Pascal, Zeiss). Cells which endocytosed anti-HER2-QDs
were ﬁxed and then reacted with anti-myosin VI (Sigma M5187) and anti-
rabbit IgG-FITC. Cells were observed under an objective-type total internal
reﬂection ﬂuorescent (TIRF) microscope (5).
Three-dimensional single particle tracking using a
confocal microscope
The optical system for the three-dimensional (3D) observation of the vesicles
consisted of an epi-ﬂuorescent microscope (IX-71, Olympus, Tokyo, Japan),
a Nipkow lens type confocal unit (CSU10, Yokokawa, Tokyo, Japan), and an
electron multiplier type charge-coupled device (CCD) camera (EM-CCD,
Ixon DV887, Andor Technology, Belfast, Ireland) (Supplementary Fig. S2
A). The objective lens (603 PlanApo, 1.45 NA, oil, Olympus) was moved by
a Piezo actuator (FL301, Nanocontrol, Tokyo, Japan) with a feedback loop
(NS202, Nanocontrol). A computer controlled the Piezo actuator that was
used to synchronize the image acquisitions. This ensured that the object lens
stayed within the exposure time of the CCD camera (Supplementary Fig. S2
B). An area;303 30 mm2 was illuminated by a green laser (532 nm,;0.01
mW/mm2 for a specimen, Crystalaser, Reno, NV).
The FIONAmethod was modiﬁed so as to observe ﬂuorescent particles in
a living cell (8). Fig. 1 A shows the ﬂuorescence images of a single QD ﬁxed
on the glass surface at various focal positions. The intensity of the image
decreased independently of the distance of the just-in-focus position. The
distribution of the intensity along the focal axis followed a Gaussian distri-
bution (Fig. 1 B). Therefore, the three-dimensional position of the ﬂuorophore
was calculated by ﬁtting the ﬂuorescent images at various focal positions
with a three-dimensional Gaussian function according to the equation,
f ðx; y; zÞ ¼ I0 exp½fðx  x0Þ21 ðy y0Þ2g=s1
3 expfðz z0Þ2=s2g1C;
where I0 is the peak intensity, (x0, y0, z0) are the positions of the ﬂuorophore,
and C is the background intensity.
The standard deviations of the position of single QD, tracked by 3D
single particle tracking, were 6 nm for the XY-plane and 45 nm for the Z axis
(Fig. 1 C). The vibration of the objective and/or the glass surface during
scanning caused a reduction in the precision of the Z axis. Artiﬁcial 100-nm
steps of the QD along the Z axis could be clearly observed with 3D single
particle tracking (Fig. 1 D).
Binning FIONA
The optical system for two-dimensional (2D) observations consisted of an
epi-ﬂuorescent microscope (IX-71, Olympus) and an electron microscopy
(EM) camera (Ixon DV860, Andor Technology). An area ;10 3 10 mm2
was illuminated by a green laser (532 nm, ;0.1 mW/mm2 for each speci-
men, Bigskylaser, Bozeman, MT) using a total internal reﬂection irradiation
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or diagonal irradiation. The ﬂuorescence of the QDs was ﬁltered (transmis-
sion wavelength of the ﬁlter was .580 nm; Omega Optics, Austin, TX).
QDs near the surface of cells were observed under an epi-ﬂuorescence
microscope using the illumination produced from total internal reﬂection (5)
and imaged on EM-CCD. QDs inside cells were also observed by diagonal
illumination. The temporal resolution was limited by the acquisition time of
the EM-CCD camera. To shorten the acquisition time, the volume of infor-
mation was reduced by binning the 16 pixels on Y axis on the CCD without
reducing the total area of observation (Fig. 2 A). The binning operation was
carried out on the software attached with the EM-CCD (Andor Technology).
This improved the acquisition time up to 0.33 ms. The ﬂuorescence image of
the ﬂuorophore was projected onto the two bins on the Y axis (Fig. 2 B). The
X-position of the ﬂuorescent spot was calculated by ﬁtting the proﬁle of the
ﬂuorescence intensity with a Gaussian curve according to the equation,
yðxÞ ¼ I expfðx  x0Þ2=2s2xg1C;
where x0, sx, and C are the position of a centroid, the width of the Gaussian
curve, and the background intensity, respectively (Fig. 2 B). The Y-position
was calculated from the difference of the ﬂuorescent intensity of the ad-
joining bins. This is similar to the nanometry used for a quadrant photodiode
(7). To obtain the Y-position at high precision, the difference in the intensity
was ﬁtted to a theoretical 2D Gaussian curve in which the width in the
Y-direction was assumed to be the same as sx (Fig. 2 C).
The spatial precision of binning FIONA was determined by moving a
single QD on the glass surface by 10 nm with a Piezo actuator (Fig. 2, D and
E). The spatial precision of the X-position was estimated to be 1.9 nm (Fig. 2
D). Although only two bins were applied to the calculation of the Y-position,
the spatial precision of Y-position was 2.0 nm, which was the same as that for
the X-position (Fig. 2 E).
Data analysis
The steps involved in the movement were automatically detected using
computer programming. In this algorithm, the following three parameters
were recognized at each step (Fig. 3).
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where xn is the position at the n-th point, and m is the number of data points
calculated. The parameter of diff indicates the difference between the mean
positions before and after the n-th point over m data points, eliminating n-th
point itself (Fig. 3 A, upper). The parameter of stder is an average of the
mean 6 SE of the data before and after the n-th point (Fig. 3 A, lower). If
motor proteins generated steps, the difference, diff, should be larger than
stder. To minimize the probability of misjudgment, a step is deemed to be a
step if it fell within a step area of diff. 3stder (Fig. 3 B). The probability of
misjudgments was only ,0.4% assuming a Gaussian distribution of the
noise and m $ 4. When the number of points within one step area was ,4,
the stepping area was omitted to minimize the misjudgment further.
Therefore, the steps that were detected were within an interval of 4 or more
points. The algorithm recognized the stepping point after the step area had
FIGURE 1 Three-dimensional single particle tracking.
(A) Image set of an optical section of a QD at various focal
positions. Upper panels are the ﬂuorescence images of the
QD at the various focal positions. Lower panels show the
3D expressions of the intensity proﬁles of the upper panels.
(B) Relationship between the focal (Z) position and the
ﬂuorescence intensity. Black line is a single Gaussian
curve ﬁtted to the intensities. The peak occurred at 0.1 mm.
(C) Spatial precision of 3D single particle tracking.
Standard deviations of tracking using 3D single particle
tracking were 6 nm (XY-plane) and 45 nm (Z axis). (D)
Precision of the Z-direction determined using 3D single
particle tracking. QDs bound on a coverslip were moved
100 nm along the focal axis by a Piezo actuator. The
movement of the QDs was tracked using 3D single particle
tracking in three dimensions. Only the Z-position of the
QD is shown here.
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been determined where the standard deviation at the n-th point over m data
points (stdev) is the maximum amount among the step area (Fig. 3 C). The
parameter of stdev was deﬁned as:
stdev ¼ 1ﬃﬃﬃﬃﬃﬃ
2m
p 3
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Finally, the data was averaged between the stepping point and the next
stepping point (Fig. 3 D).
RESULTS
3D movements of QD vesicles in cells
Human breast cancer cells of KPL-4, overexpressing HER2,
were cultured on coverslips in DMEM containing 5% FBS
(40). Just before the experiment, FBS was removed for 1 h to
starve the cells. Anti-HER2 (Trastuzumab) was used as a
vesicle marker and was bound to multiple particles of QD to
avoid the blinking effect induced by single QDs (Supple-
mentary Fig. S1). Anti-HER2-QDs were added to the cells
on the coverslip. Unbound anti-HER2-QDs were removed 2
h after their addition by washing with DMEM. Endocytosis
was triggered by the addition of 10% FBS.
The moving vesicles containing QDs were observed under
a Nipkow-type confocal microscope (Supplementary Fig.
S2) 2 h after the FBS had been added. Many QD vesicles
moved in a straight line, indicating that the QD vesicles were
transported on either the actin ﬁlaments or microtubules (Fig.
4 A and Supplementary Movie S1). To observe the sequence
of vesicular transport in three dimensions, one set of the nine
FIGURE 2 Procedure of binning FIONA. (A) Binning
of ﬂuorescent image of QD. Left panel is a part (32 3 32
pixels) of full image (1283 128 pixels) and the right panel
is a binning image with 16 pixels in the bin. The infor-
mation volume decreased 16-fold and the acquisition time
of EM-CCD improved from 2 to 0.33 ms. (B) Fluorescent
proﬁles of two bins after the binning process. Ia and Ib
indicate the ﬂuorescent intensities of a and b in right side of
panel A. (C) Calibration table for the Y axis. Calibration
curve depends on the width of the point spread function (sx).
(D and E) QD ﬁxed on a coverslip was moved by 10-nm
steps using a Piezo actuator. The position of the QDs was
determined with a temporal resolution of 330 ms, and
showed 10-nm steps with noise of 1.9 nm (X axis, D) and
2.0 nm (Y axis, E).
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confocal 3D images of the QDs were taken every 330 ms
with 1.0-mm step movements of the objective (Fig. 4 B;
Supplementary Fig. S2 and Movie S2). The 3D position of
the ﬂuorophore was calculated by ﬁtting the ﬂuorescence
images at various focal planes with 3D Gaussian functions
(3D single particle tracking) (Figs. 1 and 4 C). The Z axis in
Fig. 4 C is directed from the membrane to the nucleus
perpendicular to the cell membrane. Anti-HER2-QDs moved
in continuous lines at a velocity of 300–800 nm/s at 30C
just beneath the cell membrane (red symbols in Fig. 4, C and
D) after endocytosis (Supplementary Movie S3). Occasion-
ally the QDs paused (0.5 s on average) during their move-
ments when moving along the same lines or when changing
the direction of their movement. When the QDs were trans-
ported toward the nucleus (inward movement), their speed of
movement increased (0.8–1.5 mm/s) (blue symbols in Fig. 4,
C and D). Once close to the nucleus, the speed decreased
dramatically. In the areas in the vicinity of the nucleus, anti-
HER2-QDs moved straight for short distances (within a range
of 0.5 mm) and exhibited changes in direction (green symbols
in Fig. 4, C and D).
To determine whether QD vesicles were transported by
actin- or microtubule-based motor proteins, actin ﬁlaments
and microtubules in the chemically ﬁxed cells were stained
with phalloidin-rhodamine and FITC antibody against anti-
tubulin, respectively. Images taken with a confocal micro-
scope indicated that the actin ﬁlaments were localized directly
underneath the cell membrane, whereas the microtubules were
positioned;1 mm away from the membrane (Supplementary
Fig. S3).
To conﬁrm the relationship between the movements of
anti-HER2-QDs in the cytoplasm and the localization of the
actin and microtubules, either the actin ﬁlament or the mi-
crotubule were depolymerized by adding cytochalasin D or
nocodazole, respectively (Supplementary Fig. S4 A) (42,43).
Treating the QDs with cytochalasin D or nocodazole affected
their movement. The numbers of moving QDs beneath the
membrane, in the cytosols, and near the nucleus were counted
(Supplementary Fig. S4 B). QDs that moved slowly, ,100
nm/s with random direction, were not included in the count.
After the addition of 10 mM cytochalasin D, the number of
the QDs moving beneath the membrane decreased to 33% of
that before the treatment (22 cells). In contrast, the popula-
tion of QDs transported toward the nucleus increased up to
189% of that before the treatment. After the addition of 40
mM nocodazole, the transport of anti-HER2-QDs toward and
away from the nucleus was inhibited. The movement of anti-
HER2-QDs beneath the cell membrane was not inhibited,
but rather, increased to 122%. These results indicate that the
movements of anti-HER2-QDs beneath the membrane in-
volved the actin ﬁlaments and such motor proteins as myosin
VI or myosin V (2). Transports toward and away from the
nucleus are most likely performed by microtubule-based
motors, such as dynein or kinesin, respectively (1).
The transport of the clathrin-mediated vesicle that had
been endocytosed including the EGFR (HER1) family has
been shown to be related to myosin VI (28,29,44). To ex-
plore this further, we investigated whether myosin VI and
anti-HER2-QD colocalized beneath the membrane using an
immunoﬂuorescence method and TIRF microscopy (5). The
QDs were colocalized with myosin VI (Fig. 4 E). The prob-
ability of colocalization of QD (red) and myosin VI (green)
was 9.9 6 3.1% (10 cells measured) of all QDs located on
the membrane. The probability that the ﬂuorescent spots of
QDs overlapped randomly with those of myosin VI within a
distance of 100 nm was estimated as: (the number of myosin
VI spots) 3 (the area of myosin VI spot) / (the area of cell
body) / (the area of QD spots) 3 0.12 (mm2) 3 p ¼ 98.7 3
0.31 (mm2) / 585.4 (mm2) / 0.38 (pixels2) 3 0.12 (mm2) 3
p ¼ 0.004.
This value of 0.4% was signiﬁcantly smaller than that
obtained from the overlapped spots of 9.9% in Fig. 4 E. This
FIGURE 3 Determination of steps and step size. These panels show a
procedure of a step detection algorithm used in this study. (A) The differ-
ences between the averages of the data points in the forward and backward
over n-th data (diff) have been compared to the degree of ﬂuctuation in same
data (stder). (B) When diff was larger than 3stder the area was considered to
be a step area (orange). (C and D) The algorithm deﬁned the data that had
the maximum standard deviation (stdev, C) in one step area as a stepping
point (cyan circle, D). (E) Dwell displacement was calculated by averaging
adjoining stepping points. Left panel shows the deﬁnition of each of the pa-
rameters, diff, stder, and stdev. A detail explanation is described in Materials
and Methods.
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is consistent with the ﬁnding of ,9.9% of the anti-HER2
antibody being internalized and transported into the cells
within 2 h of the incubation previously reported (45). My-
osin V is thought to not participate in the transport of vesicles
containing QD antibody, since the anti-HER2 antibody inhib-
ited the recycling of the endosome including HER2, which is
transported by myosin V (34,35,38,39). The movement along
the actin ﬁlament in this study, therefore, could be produced
most likely by myosin VI similar to the HER1 endosome.
These results suggest that QD vesicles were transported
along actin ﬁlaments by myosin VI soon after endocytosis.
Movement of QD vesicles on actin ﬁlaments
To observe the movement of QD vesicles transported be-
neath the cell membrane with high temporal and spatial pre-
cision, 2D images at a ﬁxed focal plane were taken under
TIRF microscopy equipped with fast EM-CCD. Only the
ﬂuorescent spots emitting constant intensities were analyzed
when they moved parallel to the coverslip and near the cell
membrane, presumably on the actin ﬁlaments (Supplementary
Movie S4 and S5). Positions of the QD spots were deter-
mined using FIONA with a spatial resolution of 1.8 nm with
an imaging cycle time of 2 ms (Fig. 5 A). Stepwise move-
ments were detected using computer analysis (see Materials
and Methods). The steps detected varied greatly in size rang-
ing from 8 and 50 nm. To investigate if step size was cor-
related with time, the step sizes were plotted as a function of
time (Fig. 5 B and Supplementary Fig. S5). Stepwise changes
in step size were detected by the same method as that used
for the displacement. It was assumed that the distribution of
the step size could be well ﬁtted to a Gaussian curve similar
to that for the noise of the QD position. The average step
sizes until the step size changing were plotted in a histogram
(Fig. 5 C). The histogram showed two peaks at 17.2 and 30.9
nm ﬁtted by two Gaussian curves. This leads to the question
of whether these periods where the step sizes are different
play any signiﬁcant role in cell transport. The traces were
separated into the large step period where mean step size was
.23 nm and the small step period where steps were,23 nm.
The value of 23 nm was used because this is the middle value
FIGURE 4 Movements of anti-HER2-QDs in living cells. (A) Fluores-
cence confocal image of anti-HER2-QDs in KPL4 cells. Bar indicates 10
mm. White spots are individual vesicles labeled with anti-HER2-QD. Cyan
lines are the trajectories of the movements of individual anti-HER2-QDs for
a 10-s period. (B) Three-dimensional movement of the anti-HER2-QD. The
confocal images at various focus positions are arranged vertically. The red
spot is an example of a moving QD. (C) Three-dimensional movement of the
transport of HER2 from the membrane to the nucleus after endocytosis. Z
axis is the axis from the membrane to the nucleus, and XY-plane is parallel
with the membrane. Red, blue, and green circles indicate movement along
the membrane, transport toward the nucleus, and drift around the nucleus,
respectively. (D) The time course of the velocity of the movement in panel C
averaged for a 3-s period. Red circles indicate the movements near the
membrane, and blue circles indicate movement toward the nucleus.
Arrowheads indicate the cessation of movement. The colors correspond,
respectively, to those explained in C. (E) Colocalization of myosin VI and
anti-HER2-QD observed under the TIRF microscope. Myosin VI was
immunolabeled with anti-myosin VI and FITC-anti-IgG (green spots). Anti-
HER2-QDs bound to HER2 on the membrane, and some of the QDs
internalized into the cytoplasm after endocytosis (red spots). White arrows
indicate the QD spots that overlapped with those of myosin VI. Scale bar is 5
mm. Lower panel is an enlargement of the region depicted in cyan in the
upper panel.
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of the two Gaussian distribution shown in Fig. 5 C. The step
size and the dwell time, i.e., the time between adjacent steps,
of the small and large step period have been analyzed
separately (Fig. 5, D–G). The distribution of the step sizes
also had peaks at 15 nm for the small step period and 29 nm
for the long step period (Fig. 5, D and E). The distribution
and mean time (;30 ms) of the dwell times for the small step
periods was similar to that for long periods (Fig. 5, F and G).
FIGURE 5 Stepwise movements of the transport of the
vesicles beneath the membrane. (A) Typical traces ob-
tained for the transport beneath the membrane at 30C. Red
lines indicate the individual steps. Values are the sizes of
each step detected by the computer programming. (B)
Switching of the step size. Red lines indicate the stepwise
changes of the step size. Yellow and cyan indicate the
periods where the steps were small and large, respectively.
(C) Histogram of the average step size until the step size
changed. Data was ﬁtted with the Gaussian distribution
with peaks at 30.9 and 17.2 nm (n ¼ 25). (D and E)
Histogram of the step sizes for periods with small (D) and
large steps (E). The peak of the Gaussian distribution ﬁtted
to the data for periods where the steps were small was 15
nm with a halfwidth of 5.6 nm (n ¼ 202). The peak for the
period where the steps were large occurred at 29 nm with a
halfwidth of 10 nm (n ¼ 188). (F and G) Dwell time of
period where the steps were small (F) and large (G). The
mean dwell time of period where the steps were small
and large were 29 ms (n ¼ 202) and 32 nm (n ¼ 188),
respectively.
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To determine whether the stepwise change was a random
event as a part of noise or due to a biological process, step
sizes were compared with a result of a simulation assuming a
random event. The step sizes obtained in the experiment
were arranged at random. The number of step size changes
was counted by the method described in the Fig. 5 B. The
number of stepwise changes in the simulated step traces was
0.7 6 0.5 per 2 s (mean 6 SD, n ¼ 1400). This is consid-
erably smaller than the average number of stepwise changes
(2.4 times/2 s; n ¼ 5) obtained in the experiment (Fig. 5 B
and Supplementary Fig. S5), suggesting that most of the step-
wise change was developed not by random events, but by
actual meaningful biological events. Furthermore, to deter-
mine whether there was any correlation of step size between
successive steps in Fig. 5 B and Supplementary Fig. S5, we
had another type of an analysis that is zero crossing analysis
(Supplementary Fig. S6). The average step size of all step
sizes (24.3 nm) was deﬁned as the zero, and we counted the
data points between two successive zero upcrossings (Supple-
mentary Fig. S6 A). Assuming the step size was randomly
distributed, the dwell during zero crossing followed to the
single exponential function. The experimental data did not
show the single exponential distribution that the data sim-
ulated as random events showed (Supplementary Fig. S6 B).
This analytical result also indicates the step size change
happened due to some correlation, not randomly.
Movement of QD vesicles on microtubules
analyzed by the binning FIONA
The transport of QD vesicles rapidly toward the nucleus on
the microtubules (inward movement), which was presumably
produced by dynein, was observed a few micrometers from the
cell membrane (Fig. 6). The inward transport could be observed
by illuminating the inside of the cell on a diagonal, avoiding the
visualization of the actin-based transport. The microtubules
are congregated near the nucleus, thus a region was selected
far enough from the nucleus to show the microtubules lying
FIGURE 6 Stepwise movements of the transport of the
vesicles toward the nucleus (inward movement). (A) An
incident-light image and ﬂuorescence image obtained
using binning FIONA. To conﬁrm the direction of the
movement of vesicles, the incident-light image of the cell
was observed when the ﬂuorescence image of QD vesicles
was overlapping (left). The 16 pixels on the Y axis of the
ﬂuorescent image were binned into one bar (middle). The
8-nm step was clearly observed by using binning FIONA
(right). (B) A typical trace of the movement toward the
nucleus at 30C. Gray line is the raw data, and the black
line is the average line for the three data sets. (C) Typical
trace of the movement toward the nucleus at 20C. Blue
lines in panels A, B, and C indicate steps detected by the
computer programming. (D) Histogram of step sizes of the
movements toward the nucleus. Data was ﬁtted with four
Gaussian curves (n ¼ 318). The main peak values were
8.4 and 8.5, respectively. (E) Histogram of the dwell
times of the movements toward the nucleus. Data were
ﬁtted with single exponential function with a time constant
of 7.5 ms (n ¼ 288).
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roughly parallel to the microscope stage (Fig. 6 A, in the red
square). When the vesicle transport could be observed at a
temporal resolution of 2 ms similar to what occurs on actin
ﬁlaments, clear steps of the vesicle could not be clearly
detected. It was expected that steps ,10 nm would be gen-
erated by dynein because, from the velocity of the QD of
0.8–1.5 mm/s in cells (Fig. 4 D), dynein will take only 4–8
ms or 2–4 sampling points calculated to move from the cell
membrane to the nucleus. We developed a new analytical
method to determine the position of QDs at a higher temporal
resolution (binning FIONA). The temporal resolution of the
captured images has been improved to 330 ms by binning 16
pixels on the Y axis of CCD without reducing the observation
area (Fig. 6 A, middle, and Supplementary Movie S6). The
spatial precision or standard deviation of the noise produced
by the binning process was 1.9 nm along the X axis and 2.0
nm along the Y axis per 330 ms. This is very similar to the
value of 1.8 nm that was obtained when no binning was
performed (Fig. 2, D and E). When 6 points with the 330-ms
period were averaged for a total of 2 ms, the noise in the X
and Y axis could be reduced to 0.8 and 0.9 nm, respectively.
These values are considerably better than those obtained
without the binning process. Each step in the inward move-
ment toward the nucleus could be clearly detected by bin-
ning FIONA (Fig. 6 B and Supplementary Fig. S7). The inward
movement at 30C was composed of successive 6–10 nm
steps with occasional steps of 12–20 nm and steps in the
backward direction. To conﬁrm that the successive 8-nm
steps were not produced as a result of the binning processes,
experiments were also conducted at a lower temperature (20C,
Fig. 6 C). At the lower temperature, 8-nm steps were ob-
served with a temporal resolution of 2 ms in the absence of
binning and the successive large (.20 nm) steps were not
observed in the cytosol. The velocity was three times slower
(250–500 nm/s) than that recorded at 30C (Fig. 6 C). The
majority of the steps were also 8 nm in size inside cells,
which is consistent with those steps measured at 30C using
binning FIONA.
The histogram of the step size showed peaks at multiples
of 8.5 nm, suggesting that the elementary step size is 8 nm
(Fig. 6 D). The dwell time of the 8-nm steps in the inward
direction was analyzed as the dynein step (Fig. 6 E). The
histogram could be ﬁtted with a single exponential decay
with a time constant of 7.5 ms. Using a step size of 8.5 nm
and a dwell time of 7.5 ms, the velocity of inward transport
without backward steps was calculated to be 1100 nm/s. This
value is consistent with the data in in vitro assays (800 nm/s),
when taking into consideration the 5C difference in temper-
ature between this study and previous studies (9,10).
The outward movement of the QD vesicles, presumably
induced by kinesin, was occasionally observed after the vesi-
cles had been transported in the inward direction. The move-
ment was measured with binning FIONA because the velocity
of the movement was faster than that of the inward move-
ment. The outward movement also involved stepwise move-
ments with step sizes of 6–18 nm with some steps sometimes
occurring in the inward direction (Fig. 7 A and Supplementary
Fig. S8). A histogram of the step size showed a major peak at
8.3 nm (outward direction) and a minor peak at 8.9 nm
(inward direction) (Fig. 7 B). The histogram of the dwell
times for the outward 8-nm steps was ﬁtted to a single ex-
ponential measure with a time constant of 5.0 ms (Fig. 7 C),
performed for the inward steps (Fig. 6 E). The velocity of
outward transport without backward steps was calculated to
be 8.3/0.005 ¼ 1660 nm/s.
DISCUSSION
The anti-HER2-QDs were successfully endocytosed by
the KPL4 cells. After endocytosis, the QD vesicles were
transported just beneath the cell membrane. The 3D single
particle tracking system showed vesicles being transported
via both actin ﬁlaments and microtubules. These 3D transport
processes were consistent with the results from previous
studies (24,25), and the switching from actomyosin to
FIGURE 7 Stepwise movements from
the nucleus toward the cell membrane
(outward movement). (A) Typical trace
of the movement away from the nucleus
at 30C. Gray line is the raw data, and
the black line is average line for the
three data sets. Red lines indicate steps
detected by the computer program-
ming. (B) Histogram of the step sizes
of the movement away from the nu-
cleus. Data were ﬁtted with four Gauss-
ian curves (n ¼ 238). The main peak
values were 8.3 and 8.9, respectively.
(C) Histogram of dwell time of the
movement away from the nucleus. Data
were ﬁtted with single exponential
function with the time constant of 5.0
ms (n ¼ 180).
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microtubule-based motors was similar to that observed for an
inﬂuenza virus being infected into a cell (42).
The movement of the vesicles underneath the membrane is
most likely generated by myosin VI because the observed
step size of 29 nm (Fig. 5 E) is consistent with that for re-
combinant myosin VI of ;30 nm in vitro (13,16). However,
it is different to the step size obtained for myosin V of 36 nm
in vitro (11,12,14,18) and in living cells (46). We did not
observe any successive 36-nm step underneath the cell
membrane in this study. The colocalization of myosin VI and
anti-HER2-QD under TIRF microscopy supported the idea
that myosin VI transports the endocytic vesicle, including
HER2, along the actin network beneath the membrane.
In addition to these movements, we observed an unusual
behavior of presumably myosin VI in vivo. This movement
consisted of two distinct step sizes, 29 and 15 nm, and was
observed during transport beneath the cell membrane (Fig. 5
B). These steps were not generated by double steps of shorter
step size, i.e., 8 or 15 nm because shorter step sizes were not
observed at the lower temperature of 20C when the dwell
time is approximately three times longer (Supplementary Fig.
S9). An interesting question from this result is whether this
change in step size has any biological signiﬁcance. The number
of stepwise changes in the simulated traces using a random
arrangement of step sizes was much smaller than the number
obtained in the experiment. The difference in the number of
stepwise changes between the experiment (2.4) and the sim-
ulation (0.7) is 1.7 per 2-s interval or 0.85/s. This suggests
that the step size switches between 29 and 15 nm during myo-
sin VI mediated transport.
This change in step size during transport along myosin VI
is the ﬁrst report of this unusual behavior in living cells. The
;15 nm steps of myosin VI observed in this study have not
been previously observed in in vitro assays. The movements
of myosin VI in almost all previous in vitro assays were
recorded in conditions that were not physiological. Artiﬁcial
conditions optimized the performance of myosin VI in the
assays. For example, to dimerize the monomers of myosin
VI, a leucine zipper can be inserted into the neck domain of
myosin VI or an antibody against myosin VI can be added
in the assay solution (13,16,47). Wild-type myosin VI is a
monomer in vitro, and its step size decreased dependent on
the load (48). Such studies discussed how the step size of
myosin VI monomers decreased to ;20 nm at 1.5–2.0 pN
load, while that of the myosin VI dimer with the artiﬁcial
neck domain remained constant at ;30 nm independent of
the load. Although myosin VI is thought to exist as a mono-
mer in cells, there is a current debate as to whether monomers
of myosin VI dimerize in living cells (47–49). Therefore, two
possible models of how the step size changes in a dimer or
monomer of myosin VI must be discussed.
In the ﬁrst model, monomers of myosin VI dimerize and
function as a dimer molecule in a cell. The dimers may take
two stable state steps using either the short and long steps.
For example, recombinant dimers used to zip the long neck
domain of myosin VI exhibit a short step size of 12 6 2 nm
(50). This result suggests that the transfer between zipping
and unzipping of the neck domain regulates the step size of
myosin VI. In this study, the small step size of myosin VI in
cells (15 nm) was consistent with that of the zipped dimer
(12 nm). The steps of;29 and;15 nm could be induced by
unzipping and zipping of the dimer of myosin VI, respec-
tively. This model is consistent with the result that the dwell
time of the small and large steps was similar, suggesting that
the same dimer molecule produces both the small and large
steps. Furthermore, the variance of the step sizes also changed
in correlation with the average step size (Fig. 5, B, D, and E).
The variation of the step sizes at 0 to;500 ms was distinctly
different from the next ;500 ms, as shown in Fig. 5 B. The
ﬂexibility of the forward head of myosin VI may decide the
step size.
In the second model, myosin VI transports the vesicle as
a monomer in cell. A monomer of myosin VI could move
processively by means of cargo binding, but not without car-
goes (48). The step size of the monomer myosin VI at high
load was ;20 nm, close to the 16 nm obtained in this study,
and the distribution was also narrow when the step size was
decreased. Furthermore, the load did not affect the dwell time
whereas step size was decreased. These results are consisted
with the results in Fig. 6. Monomer myosin VI transports a
vesicle in large steps without any load. When myosin VI gets
the vesicle hung up on the actin network near the membrane,
the step size is decreased with the increase in load.
We are not able at present to decide which model is the
correct depiction of what takes place in cells. However, the
change of step sizes in this study is remarkable for cell
biology in general because it is to our knowledge the ﬁrst
such ﬁnding and represents unusual behavior in living cells.
The inward movement, which is presumably generated by
cytoplasmic dynein, occurred in successive 8-nm steps (Fig.
6, B–D), which is consistent with previous reports (20,26).
Kural et al. discussed the possibility that many dynein mol-
ecules work together because the maximum velocity of the
vesicular movements was.10 mm/s. However, in our study,
vesicles were observed moving with a mean velocity of;1.1
mm/s and a maximum velocity of ;2 mm/s at 30C. The
8-nm steps observed in the inward transport are also con-
sistent with the result that single molecules of dynein puriﬁed
from porcine brain moved using 8-nm steps (10). The out-
ward movement, which is generated by kinesin, was also
composed of successive 8-nm steps (Fig. 7, A and B). The
velocity of kinesin of 1.66 mm/s was slightly faster than that,
1.1 mm/s, observed for dynein. These values are consistent
with those obtained in in vitro assay of kinesin-1 (930 nm/s)
and dynein (800 nm/s) in the previous report, considering the
temperature for the assays in this study was 5C higher than
assays in the previous studies (7,10).
The unitary step size of cytoplasmic dynein is still being
debated (10,20,26,51). In this study successive 8-nm steps
were observed during the inward transport. Dynein produced
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mainly 8-nm steps that were not excessively large (24 or 32 nm)
steps using laser trapping nanometry and FIONA in vitro
(10). Other groups have reported large steps as well as 8-nm
steps (51). This discrepancy may arise from the difference
of the coating of the beads or proteins. Mallik and his
colleagues combined dynein molecule and bead nonspecif-
ically without any coating despite the possibility of inac-
tivating the dynein (51). In our previous study, the beads
were coated by protein A to maintain the activity of dynein
(10). It is possible that two molecules of dynein, whose one
head was inactive, took large steps because 16, 24-nm steps
were observed with multiple one-headed kinesin molecules
(52). Nan et al. also reported that dynein takes successive
16-nm steps in cells, while Kural et al. and we observed
mainly 8-nm steps (20,26). We did not observe the
successive 16-nm steps during the inward and outward
transports. Dynein might change the step size corresponding
to surrounding circumstances, i.e., the kinds of cargoes or by
the number of dynein molecules interacted.
The chemical processes involved in the stepwise move-
ment in vivo (in cell) with in vitro techniques need to be
discussed. The single exponential decay of the dwell time
during the inward and outward steps (Figs. 6 E and 7 C)
indicates that the 8-nm steps are coupled to the chemical
reaction with a single rate-limiting step, such as the ATPase
cycle. Kinesin is known to be a tight coupling motor in that
single ATP cycles are coupled with single 8-nm steps (7,53).
The inward motor, dynein, also seems to be a tight-coupled
motor. Thus, similar dwell times were recorded for both dy-
nein and kinesin in vivo and in vitro, and the viscosity of the
cytoplasm in cells did not signiﬁcantly affect the velocity of
the movement. This indicates the single molecular measure-
ments in vitro can be used to understand the biochemical
processes of the protein in vivo.
The size of the steps generated by puriﬁed myosin VI,
kinesin, and dynein in in vitro studies is reasonably consis-
tent with those in the present living cell (7,10,13,15–17). The
measurements using binning FIONA with nanometer and
submicrosecond accuracy reveals new insights into the func-
tion of motor proteins in living cells. These new methods
provide a link between the results obtained on puriﬁed pro-
teins and in living cells.
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